1
/
of
1
Elabscience
SKU:E-CL-H1426
Human RELB(V-Rel Reticuloendotheliosis Viral Oncogene Homolog B) CLIA Kit
Human RELB(V-Rel Reticuloendotheliosis Viral Oncogene Homolog B) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the HUMAN RELB (V-REL Reticuloendotheliosis Viral Oncogene Homolog B) CLIA Kit, a cutting-edge diagnostic tool designed to facilitate accurate and efficient detection of the RELB gene in human samples. This state-of-the-art kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.
The HUMAN RELB CLIA Kit leverages the advanced Chemiluminescent Immunoassay (CLIA) technology, renowned for its exceptional sensitivity and specificity. By harnessing this innovative methodology, the kit enables the identification and quantification of the RELB gene, a crucial component in various biological processes and disease pathways.
With its comprehensive and user-friendly design, the HUMAN RELB CLIA Kit offers a streamlined workflow, minimizing the complexity and time required for sample analysis. The kit includes all necessary reagents and components, meticulously optimized to ensure optimal performance and accuracy. Its intuitive instructions empower laboratory professionals to effortlessly execute the assay, yielding reliable and reproducible outcomes.
The HUMAN RELB CLIA Kit is meticulously validated and quality-controlled to guarantee consistent and dependable results. Its exceptional precision and accuracy make it an indispensable tool for researchers, clinicians, and diagnostic laboratories seeking to unravel the intricate mechanisms involving the RELB gene.
This groundbreaking diagnostic solution holds immense potential in various fields, including cancer research, immunology, and molecular biology. By providing a comprehensive understanding of the RELB gene's expression levels, this kit enables researchers to unravel its role in disease progression, therapeutic response, and prognosis.
Invest in the HUMAN RELB CLIA Kit today and unlock a world of possibilities in the realm of genetic analysis. With its unparalleled performance, reliability, and ease of use, this kit is poised to revolutionize the way we comprehend and address complex biological phenomena.
The HUMAN RELB CLIA Kit leverages the advanced Chemiluminescent Immunoassay (CLIA) technology, renowned for its exceptional sensitivity and specificity. By harnessing this innovative methodology, the kit enables the identification and quantification of the RELB gene, a crucial component in various biological processes and disease pathways.
With its comprehensive and user-friendly design, the HUMAN RELB CLIA Kit offers a streamlined workflow, minimizing the complexity and time required for sample analysis. The kit includes all necessary reagents and components, meticulously optimized to ensure optimal performance and accuracy. Its intuitive instructions empower laboratory professionals to effortlessly execute the assay, yielding reliable and reproducible outcomes.
The HUMAN RELB CLIA Kit is meticulously validated and quality-controlled to guarantee consistent and dependable results. Its exceptional precision and accuracy make it an indispensable tool for researchers, clinicians, and diagnostic laboratories seeking to unravel the intricate mechanisms involving the RELB gene.
This groundbreaking diagnostic solution holds immense potential in various fields, including cancer research, immunology, and molecular biology. By providing a comprehensive understanding of the RELB gene's expression levels, this kit enables researchers to unravel its role in disease progression, therapeutic response, and prognosis.
Invest in the HUMAN RELB CLIA Kit today and unlock a world of possibilities in the realm of genetic analysis. With its unparalleled performance, reliability, and ease of use, this kit is poised to revolutionize the way we comprehend and address complex biological phenomena.
Share
